Details of the Drug Reposition

General Information of This Drug (ID: DMDUS54)

Drug Name
K-NK002   DMDUS54
Synonyms CSTD-002-NK
Drug Type
Cell therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Myelodysplastic syndrome DISYHNUI 2A37 Phase 2 [1]
Acute myeloid leukaemia DIS0BM1I 2A60 Phase 2 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT04395092) Haplo-identical Natural Killer (NK) Cells to Prevent Post-Transplant Relapse in AML and MDS (NK-REALM). U.S. National Institutes of Health.